National Immunization Survey-Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent by week for the national-level view, and by month for the jurisdiction-level view.

National Immunization Survey-Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. Trends in behavioral indicators represent the percent of unvaccinated people responding to each of the indicators by intent status and by week for the national-level view, and by month for the jurisdiction-level view.

National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent by demographics.

Following collection of August 2021 survey data, an error in data processing led to incorrect categorization of some survey respondents; some respondents who should have been categorized as MSA: Principal City instead were categorized as MSA: Non-Principal City. Data downloaded during the period September 12, 2021 through September 30, 2021 may have incorrect estimates by MSA status, SVI of county of residence, and political leaning of county of residence.

Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Demographic Characteristics

• COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.

• COVID-19 vaccination coverage and intent among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.

Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Jurisdiction

• COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.

Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant.

• Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant.

• The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.

Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Jurisdiction

• COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.

Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Jurisdiction

• RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)

Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Demographic Characteristics

• RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)

• The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)